Cardiovascular drugs market covers the drugs
used to treat conditions that affect the heart or blood vessels. These conditions
include heart stroke, coronary artery diseases, valvular diseases, peripheral
venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis,
and lymphatic diseases. Some of the major cardiovascular drugs include
anti-hypertensive drugs such as calcium channel blockers and Angiotensin II
receptor antagonists, and hypolipidemic drugs such as fibric acid derivatives
and bile acid binding resins.
Read More:
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report-2018
The major reasons why the global
cardiovascular drugs market will increase from $130 billion in 2017 to $140
billion by 2021 are the increase in aging population, increase in the
prevalence of cardiovascular diseases and availability of more generic drugs
that reduce the cost of treatment.
In the report, the global cardiovascular drugs
market is divided into four segments namely, anti-hypertensive drugs, other
drugs for cardiovascular diseases, hypolipidemics and anti thrombotics. While
the first and the second segment accounts for nearly three-fifth of the market,
the remaining share is attributed to other two segments.
The USA was the largest
country in the cardiovascular drugs market in 2017, accounting for nearly
one-fourth of the market share. The factors attributed to the size of this
market include good quality healthcare services, high healthcare expenditure,
high levels of regulation and patent protection and the GDP of the country. Japan and
Germany followed the USA as the next largest countries in the market.
The cardiovascular drugs market is fragmented
with a number of large and small drug organizations. The top five competitors
in the market made up around 20% of the total market in 2017. Merck & Co.
was the largest competitor of the market, followed by Sanofi S.A. and Pfizer
Inc. Merck & Co. was founded in 1891 and is headquartered in New Jersey,
USA. It offers therapeutic and preventive health solutions through prescription
medicines, vaccines, biologic therapies and animal health products. Merck &
Co. serves drug wholesalers and retailers, hospitals, government agencies and
entities, physicians, physician distributors, veterinarians, distributors,
animal producers, and managed health care providers.
About The
Business Research Company.
The Business Research Company is a Business
Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and
a network of trained researchers in 15 countries globally.
Contact
Information.
The Business Research Company
Europe: +44 207
1930 708
Asia: +91
8897263534
Americas: +1 315
623 0293
No comments:
Post a Comment